The lifetime risk of developing colorectal cancer in patients with Lynch syndrome is 54–74% in men and 30–52% in women, and there are a fair number of patients with MMR variants who did not develop colorectal cancer throughout their lives. This evidence concerns the gene MRC1 and Lynch syndrome.